Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Endocrine 3CNS 3

Conditions

Glioma 2Parkinsonian Disorders 1Neoplasms 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 73Temozolomide 68Specimen Handling 48Radiotherapy 40Radiosurgery 29Bevacizumab 26Radiation 25Cyclophosphamide 25Nivolumab 21Biopsy 21pembrolizumab 20Carboplatin 16X-Rays 14Lomustine 13Ipilimumab 13fludarabine 12Irinotecan 12Vincristine 11Topotecan 11Surgical Procedures, Operative 11Cisplatin 11Blood Specimen Collection 11trametinib 9dinutuximab 9Immunoglobulin G 8Etoposide 8Doxorubicin 8lutetium Lu 177 dotatate 7fludarabine phosphate 7atezolizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
fluorodopa F 18 × CNS × 90 days × Clear all
NCT06667726 2026-04-28

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Mayo Clinic

Phase 2 Recruiting
47 enrolled
CNS

Brain Neoplasms

NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

Nuclear Imaging Institute

Phase 2 Enrolling by invitation
200 enrolled
CNS

Glioma, Neoplasms, Parkinsonian Disorders

NCT02104310 2026-04-06

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

Mayo Clinic

Active not recruiting
25 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡